Plain-Language Summary
Plain-language reading of the public trial registries.
In short
- Exenatide has been studied in people a great deal.
- 353 registered studies in total.
- 9 are still enrolling people, so this is active research, not just history.
What kind of research
- 328 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
- About 65,835 people took part in those.
- A further 25 studies only looked at records of people already taking it. These are counted separately because nobody was given the peptide for the study, so they cannot prove cause and effect.
How far along it is
- 174 trials have reached phase 3 or 4 — the large, late-stage trials regulators rely on to approve a drug.
- 166 have published results in the medical literature that anyone can read.
- The research spans 60 countries.
A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.
Filter
Showing 353 of 353 trials for Exenatide.
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
Johns Hopkins University
Multiple Sclerosis
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes Mellitus
The First Affiliated Hospital of Henan University of Science and Technology
T2DM
CHDR2418
Centre for Human Drug Research
Cardiovascular and metabolic diseases
Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant
Vivani Medical, Inc
Overweight and Obesity · Type2diabetes
Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function.
Azienda Ospedaliero-Universitaria di Parma
Healthy Volunteer
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
AstraZeneca
Pancreatic Cancer
Exendin PET/CT for imaging of paragangliomas
Stichting Radboud universitair medisch centrum
paragangliomas
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Exenatide For Reducing the Reinforcing Effects of Cocaine
Christopher D. Verrico
Cocaine Use Disorder
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin
Beijing Dongfang Biotech Co., Ltd.
Type2 Diabetes Mellitus
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients
Beijing Dongfang Biotech Co., Ltd.
Type 2 Diabetes Mellitus
Diabetes Islet Preservation Immune Treatment
Camillo Ricordi and Jay Skyler
Diabetes Mellitus, Type 1 · Hypoglycemia · Autoimmune Diseases · Diabetes Mellitus
Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects
Beijing Dongfang Biotech Co., Ltd.
Diabetes Mellitus, Type 2 · Overweight
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
Cardenal Herrera University
Chronic Kidney Disease stage3 · Chronic Kidney Disease stage4 · Chronic Kidney Disease Stage 1 · Chronic Kidney Disease Stage 2
Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
Maisa N. Feghali, MD
Gestational Diabetes
BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation
Radboud University Medical Center
Type 1 Diabetes
Exenatide for Smoking Cessation and Prevention of Weight Gain
The University of Texas Health Science Center, Houston
Smoking Cessation · Weight Gain
A Trial to Determine the Efficacy and Safety of Presendin in IIH
Invex Therapeutics Ltd.
Idiopathic Intracranial Hypertension
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Exendin PET/CT for Imaging of Paragangliomas
Radboud University Medical Center
Paraganglioma
GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
Chinese University of Hong Kong
Cerebral Small Vessel Disease
Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus
Azienda Ospedaliero-Universitaria di Parma
Type1diabetes · Type2diabetes · Pre Diabetes · Hyperinsulinism
Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetes
Cambridge University Hospitals NHS Foundation Trust
Type 2 Diabetes · Obesity
[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients
Peking Union Medical College Hospital
Insulinoma
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Hypopituitarism · Central Diabetes Insipidus · Panhypopituitarism · Psychological Disorder
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
Brigham and Women's Hospital
Cardiovascular Events · Type2 Diabetes · Renal Disease
Comparison of Type 2 Diabetes Pharmacotherapy Regimens
Kaiser Permanente
Type 2 Diabetes Mellitus · Cardiovascular Diseases
A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass
Radboud University Medical Center
Diabetes Mellitus
Exenatide for Treating Cocaine Use Disorder
The University of Texas Health Science Center, Houston
Cocaine Use Disorder
Identification and clinical relevance of an oxytocin-deficient state: randomized, crossover, placebo-controlled pilot physiopathological study: GLP1 Study.
Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
Hypopituarism
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia
University Hospital, Basel, Switzerland
Endogenous Hyperinsulinism
Brain Activation and Satiety in Children 2
Seattle Children's Hospital
Childhood Obesity
Effects of GLP-1 Analogue Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Overweight/Obese PCOS Patients With Hyperandrogenemia.
Bing He
Polycystic Ovary Syndrome
Exenatide Once-weekly as a Treatment for Multiple System Atrophy
University College, London
Multiple System Atrophy
The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma
First Affiliated Hospital of Fujian Medical University
Insulinoma
Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes Mellitus
AstraZeneca
Type 2 Diabetes
Proof of Concept Study in Patients With Short Bowel Syndrome
9 Meters Biopharma, Inc.
Short Bowel Syndrome
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy
PegBio Co., Ltd.
Type 2 Diabetes Mellitus (T2DM)
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects
PegBio Co., Ltd.
Type 2 Diabetes Mellitus (T2DM)
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
SR-Exenatide (PT320) to Eveluate Efficacy and Safety in Patients With Early Parkinson's Disease
Peptron, Inc.
Early Parkinson's Disease
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease
Neuraly, Inc.
Parkinson Disease
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Exenatide Treatment in Parkinson's Disease
Center for Neurology, Stockholm
Parkinson Disease
Exenatide
Region Stockholm – SLSO
Parkinson's disease
Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease
University College, London
Parkinson's Disease
The Effect of Exenatide on Fasting Bile Acids
Beijing Chao Yang Hospital
Type 2 Diabetes Mellitus in Obese
Glucagon Like Peptide 1 Receptor (GLP1R) Expression and Beta-cell Mass in Patients With Type 2 Diabetes
Radboud University Medical Center
Diabetes Mellitus · Diabetes Mellitus, Type 2
A Study With NLY01 in Subjects With Type 2 Diabetes
Neuraly, Inc.
Type2 Diabetes · Diabetes Mellitus, Type 2
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients
Peking Union Medical College Hospital
Polycystic Ovary Syndrome
Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.
Consano Clinical Research, LLC
Diabetes Mellitus, Type 2
Imaging Pituitary ActiVation by Exendin
Radboud University Medical Center
Diabetes Mellitus, Type 2
Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation
Mayo Clinic
Pre Diabetes
Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma
Nanjing First Hospital, Nanjing Medical University
Insulinoma
The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
Boston Medical Center
Alcohol Use Disorder
Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers
Cambridge University Hospitals NHS Foundation Trust
Cardiovascular Diseases
Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
Tianjin Medical University
GLP1-R-related Disease · Tumor · Insulinoma · Positron Emission Tomography
A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects
Neuraly, Inc.
Safety and Tolerability in Healthy Volunteers
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients
Xiangya Hospital of Central South University
Obesity
Effects of Exenatide on Motor Function and the Brain
University of Florida
Parkinson's Disease
Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria
The University of Texas Health Science Center at San Antonio
Diabetes Mellitus, Type 2
The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients
Universitätsklinikum Hamburg-Eppendorf
Obesity · Diabetes Mellitus, Type 2
GLP-1 Receptor Expression in CHI
Radboud University Medical Center
Congenital Hyperinsulinism
Research of Intensive Metabolic Intervention Before Pregnancy in PCOS
RenJi Hospital
PCOS · Impaired Glucose Tolerance
A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus Patients
Sanofi
Type 2 Diabetes Mellitus
Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM
The University of Texas Health Science Center at San Antonio
Diabetes Mellitus, Type 2
Research of Exenatide for Overweight/Obese PCOS Patients With IGR
RenJi Hospital
Polycystic Ovary Syndrome · Overweight and Obesity · Disorder of Glucose Regulation
Trial of EXenatide in Acute Ischaemic Stroke
Neuroscience Trials Australia
Acute Ischemic Stroke
Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes
University of Guadalajara
Diabetes Mellitus, Type 2
RESILIENT
University of Liverpool
Specialty: Diabetes, Primary sub-specialty: Type 2; UKCRC code/ Disease: Metabolic and Endocrine/ Diabetes mellitus
DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2
Amsterdam UMC, location VUmc
Type 2 Diabetes Mellitus · Obesity
Effect of Exenatide on Cortisol Secretion
University of Tartu
Healthy
Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?
Anders Fink-Jensen, MD, DMSci
Alcohol Dependence, in Remission · Addiction, Alcohol
IIH Pressure - a new treatment for raised brain pressure in Idiopathic Intracranial Hypertension
University of Birmingham
Idiopathic intracranial hypertension
Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection
Theracos
Type2 Diabetes Mellitus
Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.
Medical University of Vienna
Steatosis, Liver · Type2 Diabetes
Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin
Intarcia Therapeutics
Diabetes Mellitus, Type 2
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
Radboud University Medical Center
Diabetes Mellitus, Type 1 · Hypoglycemia
A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese
The First Hospital of Jilin University
Diabetes Mellitus, Type 2
Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
University Hospital, Bordeaux
Craniopharyngiomas · Hypothalamic Obesity
GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes
University at Buffalo
Type2 Diabetes · Kidney Diseases
A Study of Pharmacokinetic Comparison of Two Recombinant Exendin-4 Formulations in Chinese Healthy Male Subjects
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Type 2 Diabetes
Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases
Filip Krag Knop
Diabetes Mellitus, Type 1
Visualizing Beta Cells in Patients With a History of Gestational Diabetes
Radboud University Medical Center
Gestational Diabetes
An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes
University at Buffalo
Evaluate Ketogenic Stress
GLP1-imaging Before and After Bariatric Surgery
Radboud University Medical Center
Diabetes Mellitus, Type 2 · Bariatric Surgery Candidate
An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects
GlaxoSmithKline
Diabetes Mellitus, Type 2
A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects
GlaxoSmithKline
Diabetes Mellitus
The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers
Christina Kruuse
Stroke
Exenatide and Brown Adipose Tissue
Ingrid Jazet
Obesity
GLP-1/Basal Insulin Combination Therapy
Albany College of Pharmacy and Health Sciences
Type 2 Diabetes Mellitus
The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke
Christina Kruuse
Ischemic Stroke
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
Sanofi
Type 2 Diabetes Mellitus
Exenatide Once Weekly for Smoking Cessation
The University of Texas Health Science Center, Houston
Smoking Cessation
Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes
Weill Medical College of Cornell University
Diabetes Mellitus, Type 2
Pharmacogenomics of GLP1 Receptor Agonists
University of Maryland, Baltimore
Type 2 Diabetes
Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy
Nanfang Hospital, Southern Medical University
Diabetic Nephropathies
GLP1R-imaging in Hypoglycemia
Radboud University Medical Center
Hypoglycemia
EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
Woman's
Polycystic Ovary Syndrome · Obesity
Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity
Seattle Children's Hospital
Hypothalamic Obesity
COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial
Hospital Universitari Vall d'Hebron Research Institute
ST Elevation Acute Myocardial Infarction
GLP-1 and Hyperoxia for Organ Protection in Heart Surgery
Rigshospitalet, Denmark
Coronary Disease · Shock, Cardiogenic · Renal Failure · Stroke
Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients
Azienda Ospedaliero-Universitaria di Parma
Dysglycemia · Cognitive Deficit
Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
University of Minnesota
Hyperinsulinemic Hypoglycemia
A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients.
AstraZeneca
Type 2 Diabetes Mellitus
Study of the Effects of Intravenous Exenatide on Cardiac Repolarization
Intarcia Therapeutics
Healthy Adult Male and Female Volunteers
Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity
University of Minnesota
Severe Obesity
Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects
Karolinska Institutet
Atherosclerosis · Diabetes · Restenosis
Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide
Intarcia Therapeutics
Diabetes Mellitus, Type 2
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs
Intarcia Therapeutics
Healthy
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Study of the Effect of ITCA 650 on the PK/PD of Oral Contraceptive in Healthy Female Subjects
Intarcia Therapeutics
Healthy Adult Premenopausal Female Volunteers
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Quantitative GLP-1 Receptor Imaging Correlated to ex Vivo Distribution of In-111-exendin
Radboud University Medical Center
Diabetes Mellitus
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes
Xijing Hospital
Type 2 Diabetes Mellitus
Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
Baylor Research Institute
Type 2 Diabetes Mellitus · Chronic Kidney Disease · Left Ventricular Diastolic Dysfunction
Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function
Beijing Chao Yang Hospital
Coronary Endothelial Function
Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
Emory University
Type 2 Diabetes
Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI
Uppsala University
Obesity
Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM
Huazhong University of Science and Technology
Type 2 Diabetes Mellitus
Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment
AstraZeneca
Type 2 Diabetes
Gut Hormones in Obesity, Nicotine and Alcohol Dependence
Imperial College London
Obesity · Smoking Cessation · Alcoholism
Intravenous Exenatide in Patients With Acute Brain Injury
University of North Carolina, Chapel Hill
Brain Injuries
Effect of Gelofusine on GLP1-receptor Imaging
Radboud University Medical Center
Diabetes Mellitus, Non-Insulin-Dependent · Diabetes Mellitus
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
Hvidovre University Hospital
Type 1 Diabetes
Clinical Outcomes of Exenatide Versus Basal Insulin
AstraZeneca
Type 2 Diabetes
Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients
Centre Hospitalier Universitaire de Besancon
Quality of Life
Clinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellitus
PegBio Co., Ltd.
Type II Diabetes Mellitus
68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH
Radboud University Medical Center
Insulinoma
Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes
Fudan University
Diabetes Mellitus, Type 2 · Non-alcoholic Fatty Liver Disease
Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM
Dr. Muhammad Abdulghani
Type 2 Diabetes
Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patients
Chinese Academy of Medical Sciences, Fuwai Hospital
Type 2 Diabetes Mellitus · Heart Failure
A Comparison of Exenatide and Insulin Glargine
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Type 2 Diabetes
Exenatide for Stress Hyperglycemia
Centre Hospitalier Universitaire de Besancon
Stress Hyperglycemia
Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes
University of Palermo
Type 2 Diabetes Mellitus
Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight
Uppsala University
Obesity
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.
AstraZeneca
Type 2 Diabetes
Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects
Intarcia Therapeutics
Renal Insufficiency
GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration
Yale University
Cocaine Dependence
Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins
AstraZeneca
Type 2 Diabetes
Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
Erasme University Hospital
Type 2 Diabetes · Incretinomimetics · Pancreas
The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)
Hospital Universitari Vall d'Hebron Research Institute
Diabetes Mellitus Type 2
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
AstraZeneca
Diabetes Mellitus
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
AstraZeneca
Diabetes Mellitus
Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia
University of Massachusetts, Worcester
Schizophrenia · Schizoaffective Disorder
Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)
Mount Sinai Hospital, Canada
Type 2 Diabetes
Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status
Shanghai 10th People's Hospital
Obesity
Liver and Fat Regulation in Overweight Adolescent Girls
University of Colorado, Denver
Hepatic Steatosis · Polycystic Ovarian Syndrome · Obesity
GLP-1 Agonism Stimulates Browning of Subcutaneous White Adipose Tissue in Obesity Men
Xiang Guang-da
Obesity
Trial of Exenatide for Parkinson's Disease
University College, London
Parkinson's Disease
Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus
Phoenix VA Health Care System
Type 2 Diabetes
Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying
Mayo Clinic
Obesity
GLP-1 Analogs for Neuroprotection After Cardiac Arrest
Jesper Kjaergaard
Cardiac Arrest · Coma
The Differential Effects of Diabetes Therapy on Inflammation
University College Dublin
Diabetic Nephropathy · Type 2 Diabetes
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
OPKO Health, Inc.
Diabetes Mellitus, Type 2
Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
The University of Texas Health Science Center, Houston
Prediabetes · Obesity
Incretin-based Drugs and the Risk of Heart Failure
Canadian Network for Observational Drug Effect Studies, CNODES
Type 2 Diabetes Mellitus
Incretin-based Drugs and Pancreatic Cancer
Canadian Network for Observational Drug Effect Studies, CNODES
Diabetes Mellitus, Type 2
Incretin-based Drugs and Acute Pancreatitis
Canadian Network for Observational Drug Effect Studies, CNODES
Diabetes Mellitus, Type 2
Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy
xiaolong zhao
Type 2 Diabetes
68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis
Peking Union Medical College Hospital
Insulinoma · Nesidioblastosis
Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
Hanmi Pharmaceutical Company Limited
Type 2 Diabetes
Exenatide for Myocardial Protection During Reperfusion Study
University Health Network, Toronto
Myocardial Infarction
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
Eli Lilly and Company
Diabetes Mellitus, Type 2
New Imaging Procedure for the Localisation of Insulinoma
University Hospital, Basel, Switzerland
Endogenous Hyperinsulinaemic Hypoglycaemia
Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
Hanmi Pharmaceutical Company Limited
Type 2 Diabetes
Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Eli Lilly and Company
Type 2 Diabetes Mellitus
A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Hanmi Pharmaceutical Company Limited
Diabetes Mellitus
GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow
Zealand University Hospital
Healthy
Safety Evaluation of Adverse Reactions in Diabetes
Charles University, Czech Republic
Type 2 Diabetes Mellitus
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Yale University
Type I Diabetes
Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
Georgetown University
Gestational Diabetes
Incretin and KATP Channels
Katarina Kos
Healthy Subjects
Feasibility Study of Exenatide by Continuous Subcutaneous Infusion
GlaxoSmithKline
Obesity
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
Intarcia Therapeutics
Type 2 Diabetes
A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes
Intarcia Therapeutics
Type 2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
Amsterdam UMC, location VUmc
Type 2 Diabetes
A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.
Gilead Sciences
Type 2 Diabetes Mellitus
Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults
Vanderbilt University
Human Immunodeficiency Virus Infection · Diabetes Mellitus
Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome
Mayo Clinic
Short Bowel Syndrome
A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650
Intarcia Therapeutics
Type 2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Intarcia Therapeutics
Type 2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue
Bjorn H. Ebdrup
Obesity · Metabolic Syndrome X · Drug-induced Obesity · Schizophrenia
Autoinjector Device Assessment Study
AstraZeneca
Healthy Subjects
Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
AstraZeneca
Diabetes Type 2
A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 Diabetes
Intarcia Therapeutics
Type 2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes
Intarcia Therapeutics
Type 2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes
Intarcia Therapeutics
Type 2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes
Beijing Chao Yang Hospital
Type2 Diabetes
Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes
AstraZeneca
Diabetes Mellitus, Type 2
Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage
Huashan Hospital
Hypothalamic Obesity · Diabetes Mellitus
Pharmacology of Exenatide in Pediatric Sepsis
Seattle Children's Hospital
Septic Shock · Inflammation · Glucose Homeostasis · Organ Dysfunction
Effects of Obesity Treatments on Food Preferences and Metabolism
Imperial College London
Obesity · Type 2 Diabetes Mellitus
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
The Microvascular Function of GLP-1 and Its Analogues
Katarina Kos
Type 2 Diabetes · Obesity
FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
University of Washington
Type 2 Diabetes
Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
The First Affiliated Hospital of Xiamen University
Diabetes Mellitus, Type 2
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes
AstraZeneca
Type 2 Diabetes
Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
Vanderbilt University Medical Center
Obesity · Overweight · Craniopharyngioma
Weight Loss With Exenatide Treatment
Jody Dushay
Obesity
Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
Children's Hospital Los Angeles
Prader-Willi Syndrome
Study of laparoscopic biliopancreatic diversion modality for treatment of type 2 diabetes in patients with a BMI between 30 and 35. [Estudio y resultados de una modalidad de derivación biliopancreática laparoscópica para el tratamiento de la diabetes tipo 2 en pacientes con IMC entre 30 y 35]
Aragon Institute of Health Sciences [Instituto Aragonés de Ciencias de la Salud] (Spain)
Type 2 diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes
Yale University
Type 1 Diabetes
Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
AstraZeneca
Children and Adolescent With Type 2 Diabetes
Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women
University of California, Los Angeles
Obesity
Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients
Chang Gung Memorial Hospital
Type 2 Diabetes Mellitus
The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes
Amsterdam UMC, location VUmc
Diabetes Mellitus · Diabetes Mellitus, Type 2 · Obesity
Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass
Charles University, Czech Republic
Coronary Artery Disease · Decreased Left Ventricular Function
DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists
University of Dundee
Diabetes
GLP Analogs for Diabetes in Wolfram Syndrome Patients
Hadassah Medical Organization
Diabetes Mellitus Associated With Genetic Syndrome · Wolfram Syndrome
The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Type 2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Impact of Exenatide on Sleep Duration
University of Chicago
Type 2 Diabetes
Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist
University of Alabama at Birmingham
Type 2 Diabetes Mellitus · Bone Remodeling
A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects
AstraZeneca
Healthy Subjects
Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics
Assistance Publique Hopitaux De Marseille
Obesity · Diabetes
Efficacy of Laparoscopic Sleeve Gastrectomy and Intensive Medical Management in Obese Type 2 Diabetes
Post Graduate Institute of Medical Education and Research, Chandigarh
Diabetes Mellitus · Obesity
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
New Onset Type 1 Diabetes: Role of Exenatide
Albert Einstein College of Medicine
Type 1 Diabetes
A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease
National Institute on Aging (NIA)
Alzheimer's Disease · Mild Cognitive Impairment
The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
Taipei Veterans General Hospital, Taiwan
Type 2 Diabetes
Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus
Command Hospital, India
Type 1 Diabetes
Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes
University Hospital, Caen
Type 2 Diabetes
The Impact of Food on Blood Sugar in People With Type 2 Diabetes
HealthPartners Institute
Type 2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes
University of Colorado, Denver
Type 2 Diabetes
Exenatide in Extreme Pediatric Obesity
University of Minnesota
Obesity
Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients
Sun Yat-sen University
Diabetes Mellitus, Type 2 · Newly Diagnosed
The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes
Carl T. Hayden VA Medical Center
Type 2 Diabetes Mellitus
Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects
Dong-A Pharmaceutical Co., Ltd.
Diabetes Mellitus
Acute Effect of Exenatide on Brain Glucose Metabolism
The University of Texas Health Science Center at San Antonio
Impaired Glucose Tolerance (IGT) · Diabetes
Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study
University College, London
Parkinson's Disease
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
AstraZeneca
Type 2 Diabetes Mellitus
Impact of Exenatide on Sleep in Type 2 Diabetes
University of Chicago
Type 2 Diabetes · Sleep Disordered Breathing
A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension
AstraZeneca
Type 2 Diabetes
Effect of Exenatide on Liver and Heart Fat and Inflammation
Baylor College of Medicine
Type 2 Diabetes Mellitus
Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes
AstraZeneca
Type 2 Diabetes Mellitus
Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine
HealthPartners Institute
Type 2 Diabetes
The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET
University of Aarhus
Type 2 Diabetes
A Study in Participants With Type 2 Diabetes Mellitus
Eli Lilly and Company
Diabetes Mellitus, Type 2
Effects of Exenatide on Hypothalamic Obesity
Children's Hospitals and Clinics of Minnesota
Hypothalamic Obesity
Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans
University Health Network, Toronto
Hyperlipidemia
Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes
AstraZeneca
Type 2 Diabetes Mellitus
Effect of Additional Treatment With EXenatide in Patients With an Acute Myocardial Infarction (the EXAMI Trial)
Amsterdam UMC, location VUmc
Patients With a First Acute Myocardial Infarction to be Treated With Primary Percutaneous Coronary Intervention (PCI).
Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes
AstraZeneca
Type 2 Diabetes Mellitus
Myocardial Protection of Exenatide in AMI
Kyunghee University Medical Center
Myocardial Infarction
A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
AstraZeneca
Type 2 Diabetes Mellitus
Study Looking at Cardiovascular Effects of Exenatide, Its Blood Pressure Lowering Effect and Its Mechanisms
University of Nottingham
Type 2 Diabetes
A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide
Peptron, Inc.
Type 2 Diabetes Mellitus
Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
Albert Einstein College of Medicine
Type 1 Diabetes
Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus
Intarcia Therapeutics
Type 2 Diabetes
Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus
AstraZeneca
Type 2 Diabetes Mellitus
Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
Baylor College of Medicine
Diabetes Mellitus, Type 2 · Heart Failure, Diastolic
A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects
AstraZeneca
Type 2 Diabetes Mellitus
The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes
Baylor College of Medicine
Type 2 Diabetes
Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure
Amsterdam UMC, location VUmc
Type 2 Diabetes Mellitus · Congestive Heart Failure
GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children
University of Minnesota
Obesity, Morbid
Are early and late cardiovascular risk markers in women with polycystic ovary syndrome (PCOS) increased with concomitant non-alcoholic steatohepatitis (NASH) and can this be modified with exenatide?
Hull and East Yorkshire Hospitals NHS Trust (UK)
Polycystic ovary syndrome, non-alcoholic steatohepatitis
A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension
AstraZeneca
Type 2 Diabetes Mellitus
The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Weight Loss · Obesity
A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin
AstraZeneca
Type 2 Diabetes Mellitus
A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)
AstraZeneca
Type 2 Diabetes Mellitus
Intravenous Exenatide (Byetta) During Surgery
Thomas Jefferson University
Euglycemia · Hypoglycemia · Hyperglycemia
Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Korea
AstraZeneca
Diabetes Mellitus Type 2
Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes
Intarcia Therapeutics
Type 2 Diabetes
The Effects of Exenatide After Gastric Restriction
Advanced Specialty Care
Morbid Obesity
PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide
Amsterdam UMC, location VUmc
Glucocorticoid-induced Glucometabolic Abnormalities · Glucocorticoid-induced Beta-cell Dysfunction
Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM
The University of Texas Health Science Center at San Antonio
Diabetes
Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI
Rigshospitalet, Denmark
Myocardial Infarction
Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy
AstraZeneca
Birth Defects · Type 2 Diabetes · Preterm Birth
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Physical and Chemical Study of Atherosclerosis Mechanisms
Nazarbayev University
Myocardial Infarction · Coronary Artery Diseases · Diabetes Mellitus, Type 2 · Atherosclerosis of Femoral Artery
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults
University of Cincinnati
Weight Gain
Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
AstraZeneca
Type 2 Diabetes Mellitus
Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin
AstraZeneca
Type 2 Diabetes
Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus
AstraZeneca
Type 2 Diabetes
Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
University of Pennsylvania
Pre-diabetes · Type 2 Diabetes
A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)
Merck Sharp & Dohme LLC
The Methodology Assessment of Glucose Dependent Insulin Secretion
The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults
Yale University
Obesity · Insulin Resistance · Impaired Glucose Tolerance · Cardiovascular Disease
Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients
Saint Luke's Health System
Hyperglycemia · Acute Coronary Syndromes · Myocardial Infarction
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
AstraZeneca
Diabetes Mellitus
Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione
AstraZeneca
Type 2 Diabetes Mellitus
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Hoffmann-La Roche
Diabetes Mellitus Type 2
Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Type 2 Diabetes Mellitus
Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)
Ruhr University of Bochum
Nonalcoholic Fatty Liver Disease
Evaluation of Exenatide in Patients With Diabetic Neuropathy
University of Michigan
Type 2 Diabetes Mellitus · Diabetic Peripheral Neuropathy
GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
Sanofi
Diabetes Mellitus, Type 2
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
AstraZeneca
Type 2 Diabetes
Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)
AstraZeneca
Type 2 Diabetes Mellitus
Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects
AstraZeneca
Healthy Subjects
Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment
Novo Nordisk A/S
Diabetes Type 2
Exeantide in Type 2 Diabetes on Insulin
University at Buffalo
Type 2 Diabetes
Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes
Wu Qinan
Type 2 Diabetes
A Study to Assess the Effects of Exenatide on Insulin Secretion Rates Using a Graded Infusion of Intravenous Glucose (0000-099)(COMPLETED)
Merck Sharp & Dohme LLC
Healthy
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes Mellitus
Mannkind Corporation
Diabetes Mellitus, Type 2
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Bioenergetic Alterations After Exenatide Administration
University of Wisconsin, Madison
Healthy
A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)
AstraZeneca
Type 2 Diabetes Mellitus
Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)
AstraZeneca
Type 2 Diabetes
CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy
AstraZeneca
Type 2 Diabetes Mellitus
Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes
Profil Institut für Stoffwechselforschung GmbH
Type 2 Diabetes
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin
AstraZeneca
Type 2 Diabetes Mellitus
Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
University of Florida
Nonalcoholic Fatty Liver Disease · Type 2 Diabetes Mellitus
Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients
University Hospital, Basel, Switzerland
Hyperinsulinism · Hypoglycemia · Insulinoma
Exenatide and Weight Loss for Diabetes Prevention
Stanford University
Pre Diabetes · Insulin Resistance
The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes
St. Paul Heart Clinic
Impaired Glucose Tolerance
Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
University of California, Davis
Diabetes Complications · Fatty Liver
Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome
Garvan Institute of Medical Research
Prader-Willi Syndrome
Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol
CellTrans Inc.
Type 1 Diabetes Mellitus
A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes
AstraZeneca
Type 2 Diabetes
A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes
AstraZeneca
Type 2 Diabetes Mellitus
Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes
Bristol-Myers Squibb
Type 2 Diabetes
An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes
AstraZeneca
Type 2 Diabetes Mellitus
Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function
The University of Texas Health Science Center at San Antonio
Type 2 Diabetes · Healthy · Impaired Glucose Tolerance
Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes
Baylor College of Medicine
Type 2 Diabetes Mellitus
A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients
AstraZeneca
Obesity
A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus
AstraZeneca
Type 2 Diabetes Mellitus
Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only
GlaxoSmithKline
Diabetes Mellitus, Type 2
The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women
Beth Israel Deaconess Medical Center
Obesity · Impaired Glucose Tolerance
Role of Exenatide in Type 1 Diabetes
Montefiore Medical Center
Type 1 Diabetes
How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics
Oregon Health and Science University
Type 2 Diabetes
Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes
AstraZeneca
Type 2 Diabetes Mellitus
Effect on Weight Loss of Exenatide Versus Placebo
AstraZeneca
Type 2 Diabetes Mellitus
Exenatide Versus Glimepiride in Patients With Type 2 Diabetes
AstraZeneca
Type 2 Diabetes Mellitus
Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes
AstraZeneca
Type 2 Diabetes
A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes
AstraZeneca
Type 2 Diabetes Mellitus
Safety and Efficacy of Exenatide as Monotherapy
AstraZeneca
Type 2 Diabetes Mellitus
Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation
Carl T. Hayden VA Medical Center
Type 2 Diabetes Mellitus · Impaired Glucose Tolerance
Role of Exenatide in NASH-a Pilot Study
Indiana University
Nonalcoholic Fatty Liver Disease
The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes
Joslin Diabetes Center
Type 2 Diabetes Mellitus
A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients
AstraZeneca
Type 2 Diabetes
Exenatide and Metformin Therapy in Overweight Women With PCOS
Metabolic Center of Louisiana Research Foundation
Polycystic Ovary Syndrome
Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)
AstraZeneca
Type 2 Diabetes Mellitus
Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus
AstraZeneca
Type 2 Diabetes Mellitus
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin
AstraZeneca
Type 2 Diabetes Mellitus
The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females
AstraZeneca
Type 2 Diabetes Mellitus
An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
AstraZeneca
Diabetes Mellitus, Type 2
In-patient Study in Patients With Type 2 Diabetes Mellitus
GlaxoSmithKline
Type 2 Diabetes Mellitus · Diabetes Mellitus, Type 2
Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes
AstraZeneca
Type 2 Diabetes Mellitus
Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes
AstraZeneca
Type 2 Diabetes Mellitus
A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes
AstraZeneca
Type 2 Diabetes Mellitus
Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
University of Illinois at Chicago
Diabetes Mellitus, Type 1
A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents
AstraZeneca
Type 2 Diabetes (Treated With Exenatide or Other Oral Antidiabetic Therapies) · Healthy Subjects (Treated With no Diabetes Therapies)
Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes
AstraZeneca
Type 2 Diabetes Mellitus
Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy
AstraZeneca
Type 2 Diabetes Mellitus
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
AstraZeneca
Type 2 Diabetes Mellitus
Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents
AstraZeneca
Type 2 Diabetes Mellitus
An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus
AstraZeneca
Type 2 Diabetes Mellitus
Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
AstraZeneca
Diabetes Mellitus, Type 2
Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus
AstraZeneca
Diabetes Mellitus, Type 2
Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes
AstraZeneca
Diabetes Mellitus
Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
AstraZeneca
Diabetes Mellitus, Type 2
Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes
AstraZeneca
Diabetes Mellitus, Type 2
Extension Study for 2993-112
AstraZeneca
Type 2 Diabetes Mellitus
Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination
AstraZeneca
Diabetes Mellitus, Type 2
Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
AstraZeneca
Diabetes Mellitus, Non-Insulin-Dependent
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
AstraZeneca
Diabetes Mellitus, Non-Insulin-Dependent
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
AstraZeneca
Diabetes Mellitus, Type 2
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea
AstraZeneca
Diabetes Mellitus, Non-Insulin-Dependent
GEN-100
Genesis Pharma S.A.
Acute Ischemic Stroke
A GLP-1 receptor PET imaging add-on study within the VERA-T1D trial investigating the effects on beta cell mass (Image-VER-A-T1D)
Radboud universitair medisch centrum Stichting
type 1 diabetes mellitus
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Exenatide is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.